TRIAXIN-S

This brand name is authorized in Nigeria.

Active ingredients

The drug TRIAXIN-S contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone
2	Sulbactam UNII DKQ4T82YE6 - SULBACTAM SODIUM
	Read more about Sulbactam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3579	Injection	TRIAXIN - S INJECTION INJ 1000 mg; 500 mg 1 X 1VIAL +10ML WFI	38 CMS-PP-202354 TRIAXIN - S INJECTION CEFTRIAXONE SODIUM 1G, + SULBACTAM SODIUM 0.5 CEFTRIAXONE SODIUM 1G , SULBACTAM SODIUM 0.5G B4-3579 Drugs Imported Products 11VIAL +10ML WFI Prescription Only Medicine (POM) 9/16/2021 CLARION MEDICALS LTD, AFOLABI LESHI STREET, ILUPEJU ILUPEJU LAGOS 18043564 clarionorder@yahoo.com CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG)CO. LTD, 88 YANGZI ROAD, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE OF SHIJIAZHUANG, CHINA, China	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD63		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD63

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3579